Liang Xu

Representing Baosteel on its investments and proposed acquisitions in Africa, Canada, Southeast Asia and Brazil for mining resources.

Representing a Chinese conglomerate on its distressed acquisition of a mining company in Australia.

Representing a leading US technology company on its regulatory and JV transactions in China. 

Representing a major European automobile maker on its exit options for its Chinese joint venture in financial difficulty.

Representing a European OEM on its proposed investment in a Chinese autonomous driving startup.

Representing Cinda, a leading Chinese distressed investor, on its multibillion financing transactions in the real estate, mining and other sectors

Representing HNA on its sale of a global business for US$1.2bn.

Representing Jiangsu Jinsheng Industrial Co., Ltd. on its US$ 1.5 billion reverse takeover of a Chinese public company, injecting global assets from 12 jurisdictions, under the Saurer brand.

Representing Applied Materials on its M&A transactions in China.

Representing China Rail on its investments and acquisitions in Italy, Germany and South Africa.

Representing Guangzhou Automobile Group Co., Ltd. on its US$100m investment in Uber China and related restructuring.

Representing Chinese investors including the Landbridge Group on acquisition of port assets in Panama for approximately US$200m.

Representing Cinda, China's leading distressed investor, on the acquisition of a real estate development project in Beijing for US$1.6bn.

Representing a major Chinese e-commerce company on its joint venture in Southeast Asia.

Representing KPP on its US$650m acquisition of selected assets from Eastman Kodak Company, including assets and entities in China.

Representing TE Connectivity on its acquisition of two private Chinese companies in Xiamen.

Representing Texas Instruments on acquiring a major Chinese semiconductor manufacturing facility in Chengdu.

Representing ALSTOM on the public takeover of Wuhan Boiler, a company listed on Shenzhen Stock Exchange.

Representing global pharmaceutical company Actavis on its acquisition and disposal of several pharm manufacturing facilities in China.

Representing a leading global English language training provider on the cooperation with Chinese partners to establish JV educational operations in China.